Filing Details

Accession Number:
0001209191-22-012315
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-23 17:17:55
Reporting Period:
2022-02-18
Accepted Time:
2022-02-23 17:17:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1435049 Chinook Therapeutics Inc. KDNY Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1823187 James Andrew King C/O Chinook Therapeutics, Inc.
400 Fairview Ave. No., 9Th Floor
Seattle WA 98102
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-02-18 2,500 $13.00 5,897 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.